0001179110-14-012749.txt : 20140812
0001179110-14-012749.hdr.sgml : 20140812
20140812154734
ACCESSION NUMBER: 0001179110-14-012749
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140808
FILED AS OF DATE: 20140812
DATE AS OF CHANGE: 20140812
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRUKER CORP
CENTRAL INDEX KEY: 0001109354
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043110160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978663-3660
MAIL ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP
DATE OF NAME CHANGE: 20030721
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER DALTONICS INC
DATE OF NAME CHANGE: 20000315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WAGNER CHARLES F JR
CENTRAL INDEX KEY: 0001223348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30833
FILM NUMBER: 141033867
MAIL ADDRESS:
STREET 1: C/O MILLIPORE CORP
CITY: BILLERICA
STATE: MA
ZIP: 01820
4
1
edgar.xml
FORM 4 -
X0306
4
2014-08-08
0
0001109354
BRUKER CORP
BRKR
0001223348
WAGNER CHARLES F JR
C/O BRUKER CORPORATION
40 MANNING ROAD
BILLERICA
MA
01821
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2014-08-08
4
A
0
25895
0
A
121987
D
Stock Option (Right to Buy)
20.68
2014-08-08
4
A
0
49400
0
A
2024-08-08
Common Stock
49400
49400
D
Shares of restricted common stock vest in four equal annual installments on the anniversary of the grant date, commencing August 8, 2015.
The option vests in four equal annual installments on the anniversary of the grant date, commencing August 8, 2015.
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Michael Rich Attorney-in-Fact
2014-08-12
EX-24
2
ex24wagner.txt
POWER OF ATTORNEY
Exhibit 24
POWER OF ATTORNEY
Know all by these present that the undersigned
hereby constitutes and appoints each of Jodi Giordano
and Michael Rich of Bruker Corporation, signing
singly, the undersigned's true and lawful attorney-in-fact
to:
(1) execute for and on behalf of the
undersigned, in the undersigned's capacity as an officer
and/or director of Bruker Corporation (the "Company"), \
Forms 3, 4 and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on
behalf of the undersigned which may be necessary or desirable
to complete and execute any such Form 3, 4 or 5, complete
and execute any amendment or amendments thereto, and timely
file such form with the United States Securities and
Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any type whatsoever
in connection with the foregoing which, in the opinion of
such attorney-in-fact, may be of benefit to, in the best
interest of, or legally required by, the undersigned, it
being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to
this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-
in-fact full power and authority to do and perform any and
every act and thing whatsoever requisite, necessary, or
proper to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes
as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys-in-
fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming,
any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required to
file Forms 3, 4 and 5 with respect to the undersigned's
holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this 14th day of
May 2014.
/s/Charles Wagner WITNESS: /s/Rich Stein
May 14, 2014